Jiangsu Lianhuan Pharmaceutical Balance Sheet Health
Financial Health criteria checks 2/6
Jiangsu Lianhuan Pharmaceutical has a total shareholder equity of CN¥1.5B and total debt of CN¥780.6M, which brings its debt-to-equity ratio to 50.6%. Its total assets and total liabilities are CN¥2.9B and CN¥1.4B respectively. Jiangsu Lianhuan Pharmaceutical's EBIT is CN¥190.4M making its interest coverage ratio 7.7. It has cash and short-term investments of CN¥148.1M.
Key information
50.6%
Debt to equity ratio
CN¥780.55m
Debt
| Interest coverage ratio | 7.7x |
| Cash | CN¥148.10m |
| Equity | CN¥1.54b |
| Total liabilities | CN¥1.38b |
| Total assets | CN¥2.93b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 600513's short term assets (CN¥1.3B) do not cover its short term liabilities (CN¥1.4B).
Long Term Liabilities: 600513's short term assets (CN¥1.3B) exceed its long term liabilities (CN¥27.2M).
Debt to Equity History and Analysis
Debt Level: 600513's net debt to equity ratio (41%) is considered high.
Reducing Debt: 600513's debt to equity ratio has increased from 20.1% to 50.6% over the past 5 years.
Debt Coverage: 600513's debt is not well covered by operating cash flow (16.4%).
Interest Coverage: 600513's interest payments on its debt are well covered by EBIT (7.7x coverage).